L. Blanco-Colio

发表

New players in the pathogenesis of atherosclerosis

A. Ortiz, J. Egido, L. Blanco-Colio, 2007 .

AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences.

A. Ortiz, J. Egido, L. Blanco-Colio, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Plasma fingerprinting with GC-MS in acute coronary syndrome

J. Egido, C. Barbas, A. García, 2009, Analytical and bioanalytical chemistry.

The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2015, Cardiology.

Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2006, Atherosclerosis.

Atorvastatin Reduces the Expression of Prostaglandin E2 Receptors in Human Carotid Atherosclerotic Plaques and Monocytic Cells: Potential Implications for Plaque Stabilization

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2006, Journal of cardiovascular pharmacology.

Tumor Necrosis Factor‐Like Weak Inducer of Apoptosis or Fn14 Deficiency Reduce Elastase Perfusion‐Induced Aortic Abdominal Aneurysm in Mice

L. Burkly, J. Egido, L. Blanco-Colio, 2014, Journal of the American Heart Association.

Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activation in mononuclear cells and circulating MCP-1 concentrations in healthy volunteers during a fat-enriched diet.

R. Lamuela-Raventós, J. Egido, L. Blanco-Colio, 2007, Atherosclerosis.

Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2008, Kidney international. Supplement.

Mechanisms of action of statins in stroke

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2007, Expert opinion on therapeutic targets.

Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients.

J. Egido, F. Vivanco, L. Blanco-Colio, 2006, Journal of the American Society of Nephrology : JASN.

Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study.

J. Egido, L. Blanco-Colio, M. Ruíz-Ortega, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options

J. Michel, J. Egido, L. Blanco-Colio, 2012, Thrombosis and Haemostasis.

Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases

L. Blanco-Colio, J. Martín-Ventura, C. Roncal, 2022, Frontiers in Cell and Developmental Biology.

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK

J. Carrero, A. Ortiz, J. Egido, 2011, Proteomics. Clinical applications.

Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor kappaB in peripheral blood mononuclear cells from healthy men.

J. Egido, P. Pérez-Martínez, J. López-Miranda, 2004, The American journal of clinical nutrition.

Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors

J. Egido, L. Blanco-Colio, J. Tuñón, 2007, Vascular health and risk management.

Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk.

Lawrence A Leiter, A. Langer, J. Egido, 2008, European journal of pharmacology.

Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet.

J. Egido, F. Vivanco, L. Blanco-Colio, 2003, Cardiovascular research.

Statins in Hypertensive Patients: Potential Explanations for the ASCOT-LLA Study Results

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2012, Drugs.

Intensive treatment with statins and the progression of cardiovascular diseases: the beginning of a new era?

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm

I. Ezkurdia, J. Michel, J. Egido, 2016, Scientific Reports.

ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression

J. Michel, E. Calvo, J. Egido, 2015, Thrombosis and Haemostasis.

Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2008, The American journal of cardiology.

Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio

J. Michel, J. Egido, J. Emmerich, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Clinical and Population Studies Peripheral Artery Disease Is Associated With a High CD 163 / TWEAK Plasma Ratio

J. Michel, J. Egido, J. Emmerich, 2010 .

Pathophysiology of abdominal aortic aneurysm: biomarkers and novel therapeutic targets

L. Blanco-Colio, J. Martín-Ventura, M. Orriols, 2019, Clínica e Investigación en Arteriosclerosis (English Edition).

Targeting chemokines in proteinuria-induced renal disease

A. Ortiz, J. Egido, C. Gómez-Guerrero, 2012, Expert opinion on therapeutic targets.

Parathormone levels are independently associated with the presence of left ventricular hypertrophy in patients with coronary artery disease

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2015, The journal of nutrition, health & aging.

LDL induces parathyroid hormone-related protein expression in vascular smooth muscle cells: Modulation by simvastatin.

P. Esbrit, J. Egido, L. Blanco-Colio, 2008, Atherosclerosis.

3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.

Á. Pascual, J. Egido, L. Blanco-Colio, 2002, Atherosclerosis.

Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells.

J. Egido, F. Vivanco, Purificación Hernández-Vargas, 2002, Atherosclerosis.

Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.

J. Carrero, A. Ortiz, J. Egido, 2009, Clinical journal of the American Society of Nephrology : CJASN.

N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2021, Journal of clinical medicine.

N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2015, PloS one.

HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis.

J. Egido, Ó. López-Franco, C. Gómez-Guerrero, 2012, Cardiovascular research.

TWEAK/Fn14 interaction promotes oxidative stress through NADPH oxidase activation in macrophages.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2015, Cardiovascular research.

Cell Stress Proteins in Atherothrombosis

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2012, Oxidative medicine and cellular longevity.

Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.

F. Rodríguez‐Artalejo, J. Egido, I. Mahíllo-Fernández, 2014, The American journal of cardiology.

Glomerular haematuria, renal interstitial haemorrhage and acute kidney injury.

A. Ortiz, J. Egido, L. Blanco-Colio, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells.

L. Burkly, J. Egido, Ó. López-Franco, 2011, Cardiovascular research.

NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2022, Journal of clinical medicine.

MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2021, Journal of clinical medicine.

Intensive Treatment With Atorvastatin Reduces Inflammation in Mononuclear Cells and Human Atherosclerotic Lesions in One Month

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2005, Stroke.

The chronic intake of a Mediterranean diet enriched in virgin olive oil, decreases nuclear transcription factor kappaB activation in peripheral blood mononuclear cells from healthy men.

J. Egido, P. Pérez-Martínez, J. López-Miranda, 2007, Atherosclerosis.

analysisusing cDNA representational difference Heterogeneity of gene expression in human atheroma

J. Michel, P. Weissberg, J. Egido, 2015 .

Association of ficolin‐3 with abdominal aortic aneurysm presence and progression

J. Michel, J. Egido, J. Lindholt, 2017, Journal of thrombosis and haemostasis : JTH.

Identification by a Differential Proteomic Approach of Heat Shock Protein 27 as a Potential Marker of Atherosclerosis

J. Michel, O. Jensen, J. Egido, 2004, Circulation.

Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2017, Clinical science.

Vascular proteomics, a translational approach: from traditional to novel proteomic techniques

J. Egido, J. López, L. Blanco-Colio, 2009, Expert review of proteomics.

Annexins: Involvement in cholesterol homeostasis, inflammatory response and atherosclerosis

L. Blanco-Colio, J. Martín-Ventura, N. Mendez-Barbero, 2021, Clínica e Investigación en Arteriosclerosis (English Edition).

Complement C5 Protein as a Marker of Subclinical Atherosclerosis.

V. Fuster, J. Michel, B. Ibáñez, 2020, Journal of the American College of Cardiology.

Galectin-3 is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2020, Journal of clinical medicine.

Galectin‐3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis

A. Ortiz, J. Egido, J. Lindholt, 2014, Journal of the American Heart Association.

Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor B in peripheral blood mononuclear cells

P. Pérez-Martínez, F. Perez-Jimenez, C. Marin, 2004 .

Lipophilic statins induce apoptosis of human vascular smooth muscle cells.

B. Kasiske, Z. Massy, W. Keane, 1999, Kidney international. Supplement.

Hyperlipidemia-Associated Renal Damage Decreases Klotho Expression in Kidneys from ApoE Knockout Mice

A. Ortiz, J. Blanco, J. Egido, 2013, PloS one.

Tumor Necrosis Factor–Like Weak Inducer of Apoptosis (TWEAK) Enhances Vascular and Renal Damage Induced by Hyperlipidemic Diet in ApoE-Knockout Mice

A. Sanz, A. Ortiz, L. Burkly, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques.

S. Mohammed, O. Jensen, J. Egido, 2007, European journal of pharmacology.

Proteomic and Metabolomic Profiles in Atherothrombotic Vascular Disease

J. Michel, J. Egido, C. Barbas, 2010, Current atherosclerosis reports.

Impaired HDL (High-Density Lipoprotein)-Mediated Macrophage Cholesterol Efflux in Patients With Abdominal Aortic Aneurysm—Brief Report

M. Jauhiainen, J. Metso, J. Lindholt, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2022, Clínica e Investigación en Arteriosclerosis (English Edition).

Parathormone levels add prognostic ability to N‐terminal pro‐brain natriuretic peptide in stable coronary patients

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2021, ESC heart failure.

Protective effect of suppressor of cytokine signalling 1‐based therapy in experimental abdominal aortic aneurysm

I. Prieto, J. Egido, C. Gómez-Guerrero, 2020, British journal of pharmacology.

Proteomic Analysis of Polymorphonuclear Neutrophils Identifies Catalase as a Novel Biomarker of Abdominal Aortic Aneurysm: Potential Implication of Oxidative Stress in Abdominal Aortic Aneurysm Progression

J. Michel, J. Egido, J. López, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints.

J. Egido, C. Barbas, M. Malet‐Martino, 2009, Journal of proteome research.

Connective Tissue Growth Factor Is a Mediator of Angiotensin II–Induced Fibrosis

J. Egido, L. Blanco-Colio, M. Ruíz-Ortega, 2003, Circulation.

Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation.

J. Carrero, J. Egido, L. Blanco-Colio, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia

M. Sánchez-Niño, A. Sanz, A. Ortiz, 2009, Journal of cellular and molecular medicine.

The cytokine TWEAK modulates renal tubulointerstitial inflammation.

M. Sánchez-Niño, A. Sanz, J. Blanco, 2008, Journal of the American Society of Nephrology : JASN.

Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells.

A. Ortiz, J. Egido, L. Blanco-Colio, 2003, Kidney international.

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges

L. Blanco-Colio, J. Martín-Ventura, N. Mendez-Barbero, 2020, Cells.

Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection

J. Egido, M. Genebat, L. Blanco-Colio, 2014, PloS one.

Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.

T. Mak, J. Egido, C. Pastor-Vargas, 2016, Cardiovascular research.

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2016, PloS one.

From tissue iron retention to low systemic haemoglobin levels, new pathophysiological biomarkers of human abdominal aortic aneurysm

J. Michel, T. Lefèbvre, L. Gouya, 2014, Thrombosis and Haemostasis.

TWEAKing renal injury.

M. Sánchez-Niño, A. Sanz, A. Ortiz, 2008, Frontiers in bioscience : a journal and virtual library.

[Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease].

F. Rodríguez‐Artalejo, J. Egido, I. Mahíllo-Fernández, 2015, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice

S. Moestrup, J. Egido, L. Blanco-Colio, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST.

A. Langer, G. Gensini, J. Egido, 2008, Kidney international. Supplement.

IgG Anti-High Density Lipoprotein Antibodies Are Elevated in Abdominal Aortic Aneurysm and Associated with Lipid Profile and Clinical Features

J. Michel, J. Lindholt, L. Blanco-Colio, 2019, Journal of clinical medicine.

Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm.

J. Michel, J. Golledge, P. Norman, 2012, Atherosclerosis.

A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis

J. Michel, Pablo Minguez, J. Egido, 2019, EBioMedicine.

The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock.

J. Cuesta-Herranz, L. Blanco-Colio, A. Díaz‐Perales, 2020, The Journal of allergy and clinical immunology.

TWEAK and the kidney: the dual role of a multifunctional cytokine.

A. Sanz, R. Selgas, M. C. Izquierdo, 2011, Advances in experimental medicine and biology.

Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.

J. Egido, S. Urbonavičius, J. Lindholt, 2011, Atherosclerosis.

Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2020, Journal of clinical medicine.

Fcγ receptor activation mediates vascular inflammation and abdominal aortic aneurysm development

I. Prieto, J. Egido, C. Gómez-Guerrero, 2021, Clinical and translational medicine.

TWEAK Promotes Peritoneal Inflammation

M. Sánchez-Niño, J. Jimenez-Heffernan, A. Sanz, 2014, PloS one.

The Rho-kinase pathway regulates angiotensin II-induced renal damage.

J. Egido, L. Blanco-Colio, M. Ruíz-Ortega, 2005, Kidney international. Supplement.

Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution.

J. Michel, J. Egido, J. Lindholt, 2010, Atherosclerosis.

Statin use in aortic aneurismal disease to prevent progression and cardiovascular events: review of experimental and clinical data C.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2013, Current vascular pharmacology.

Assessment of biomarkers and predictive model for short-term prospective abdominal aortic aneurysm growth-A pilot study.

L. Blanco-Colio, J. Martín-Ventura, M. Vega de Céniga, 2014, Annals of vascular surgery.

Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2009, Cardiovascular research.

The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.

J. Egido, J. Paramo, L. Blanco-Colio, 2009, Atherosclerosis.

Anti-inflammatory and immunomodulatory effects of statins.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2003, Kidney international.

Animal Models of Cardiovascular Diseases

Beñat Mallavia, Carmen Gomez-Guerrero, Alberto Ortiz, 2011, Journal of biomedicine & biotechnology.

Proteomics in atherothrombosis: a future perspective

J. Michel, J. Egido, C. Gómez-Guerrero, 2007, Expert review of proteomics.

Role of complement system in pathological remodeling of the vascular wall.

C. Gómez-Guerrero, L. Blanco-Colio, J. Martín-Ventura, 2019, Molecular immunology.

Biomarkers in cardiovascular medicine.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2009, Revista espanola de cardiologia.

TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21

M. Sánchez-Niño, A. Sanz, A. Ortiz, 2010, PloS one.

TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases

L. Blanco-Colio, 2014, Front. Immunol..

Trail and vascular injury.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2007, Frontiers in bioscience : a journal and virtual library.

Phase IV prospective clinical study to evaluate the effect of taurine on liver function in postsurgical adult patients requiring parenteral nutrition.

J. Egido, J. I. Botella, L. Blanco-Colio, 2014, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm

J. Michel, E. Bonzón-Kulichenko, L. Blanco-Colio, 2019, EBioMedicine.

Impacto de los niveles plasmáticos de pro-péptido natriurético tipo B aminoterminal, proteína quimiotáctica de monocitos-1 y galectina 3 en la capacidad predictiva de eventos de la escala clínica LIPID en la enfermedad coronaria estable

F. Rodríguez‐Artalejo, J. Egido, I. Mahíllo-Fernández, 2015 .

Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men.

J. Egido, P. Pérez-Martínez, J. López-Miranda, 2009, Atherosclerosis.

Proteomic Analysis of Circulating Monocytes Identifies Cathepsin D as A Potential Novel Plasma Marker of Acute Coronary Syndromes

J. Egido, F. Vivanco, L. Blanco-Colio, 2008 .

Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration.

A. Langer, J. Egido, L. Blanco-Colio, 2007, American heart journal.

Essential Role of TGF-β/Smad Pathway on Statin Dependent Vascular Smooth Muscle Cell Regulation

A. Ortiz, J. Egido, L. Blanco-Colio, 2008, PloS one.

Red Wine Intake Prevents Nuclear Factor-&kgr;B Activation in Peripheral Blood Mononuclear Cells of Healthy Volunteers During Postprandial Lipemia

J. Egido, L. Blanco-Colio, J. Gómez-Gerique, 2000, Circulation.

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells.

J. Egido, L. Blanco-Colio, Jesús Egido, 2002, European journal of pharmacology.

Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2015, Journal of cardiology.

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Decrease Fas Ligand Expression and Cytotoxicity in Activated Human T Lymphocytes

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2003, Circulation.

Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets

A. Briones, L. Blanco-Colio, J. Martín-Ventura, 2017, International journal of molecular sciences.

Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2015, Free radical biology & medicine.

Increased Soluble Fas Plasma Levels in Subjects at High Cardiovascular Risk: Atorvastatin on Inflammatory Markers (AIM) Study, a Substudy of ACTFAST

A. Langer, G. Gensini, J. Egido, 2007, Arteriosclerosis, thrombosis, and vascular biology.

A slit in podocyte death.

M. Sánchez-Niño, A. Sanz, A. Ortiz, 2008, Current medicinal chemistry.

Considering TWEAK as a target for therapy in renal and vascular injury.

A. Sanz, A. Ortiz, J. Egido, 2009, Cytokine & growth factor reviews.

TWEAK and Fn14. New players in the pathogenesis of atherosclerosis.

A. Ortiz, J. Egido, L. Blanco-Colio, 2007, Frontiers in bioscience : a journal and virtual library.

Fn14 Is Upregulated in Cytokine-Stimulated Vascular Smooth Muscle Cells and Is Expressed in Human Carotid Atherosclerotic Plaques: Modulation by Atorvastatin

A. Ortiz, J. Egido, L. Blanco-Colio, 2006, Stroke.

3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.

A. Ortiz, C. Alonso, J. Egido, 1998, Circulation research.

Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm progression.

J. Egido, J. López, L. Blanco-Colio, 2016, Clinical science.

Identification of Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (sTWEAK) as a Possible Biomarker of Subclinical Atherosclerosis

J. Michel, A. Ortiz, J. Egido, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease.

J. Carrero, A. Ortiz, J. Egido, 2009, Clinical journal of the American Society of Nephrology : CJASN.

HMG-CoA Reductase Inhibitors Decrease Angiotensin II–Induced Vascular Fibrosis: Role of RhoA/ROCK and MAPK Pathways

J. Egido, L. Blanco-Colio, M. Ruíz-Ortega, 2007, Hypertension.

Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatin.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2004, Journal of the American College of Cardiology.

Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease.

E. Fernández, J. Egido, L. Blanco-Colio, 2017, Atherosclerosis.

Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice

L. Burkly, J. Egido, C. Pastor-Vargas, 2014, Journal of cellular and molecular medicine.

Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.

J. Carrero, A. Ortiz, J. Egido, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis

J. Rodriguez, J. Ordovás, B. Ibáñez, 2022, EBioMedicine.

Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm.

J. Michel, J. Egido, J. Lindholt, 2015, International journal of cardiology.

Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells.

A. Ortiz, J. Egido, C. Gómez-Guerrero, 2009, Cardiovascular research.

Proteomic Analysis of Intraluminal Thrombus Highlights Complement Activation in Human Abdominal Aortic Aneurysms

E. Calvo, J. Egido, J. Lindholt, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Identification of Peroxiredoxin-1 as a Novel Biomarker of Abdominal Aortic Aneurysm

J. Michel, E. Calvo, J. Egido, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Effect of atorvastatin on circulating hsCRP concentrations: a sub-study of the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study.

Lawrence A Leiter, A. Gori, A. Langer, 2010, International journal of cardiology.

The proteomic approach in the development of prognostic biomarkers in atherothrombosis.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2009, Recent patents on cardiovascular drug discovery.

Macrophage Cholesterol Efflux Downregulation Is Not Associated with Abdominal Aortic Aneurysm (AAA) Progression

J. Lindholt, L. Blanco-Colio, J. Martín-Ventura, 2020, Biomolecules.

Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.

J. Egido, Ó. López-Franco, L. Blanco-Colio, 2010, Cardiovascular research.

Proteomic approach in the search of new cardiovascular biomarkers.

A. Lázaro, J. Egido, F. Vivanco, 2005, Kidney international. Supplement.

Quest for novel cardiovascular biomarkers by proteomic analysis.

Fernando Vivanco, J. Michel, J. Egido, 2005, Journal of proteome research.

Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease.

J. Valdivielso, E. Fernández, J. Egido, 2018, Atherosclerosis.

Expression and Cytotoxicity in Activated Human T Lymphocytes 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Decrease Fas Ligand

J. Egido, L. Blanco-Colio, B. Muñóz-García, 2003 .

Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation.

J. Michel, P. Rossignol, J. Egido, 2007, Atherosclerosis.

Heat-shock proteins in cardiovascular disease.

J. Michel, J. Egido, L. Blanco-Colio, 2011, Advances in clinical chemistry.

NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2004, Stroke.

Biological Significance of Decreased HSP27 in Human Atherosclerosis

J. Michel, J. Egido, L. Blanco-Colio, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Label‐free proteomic analysis of red blood cell membrane fractions from abdominal aortic aneurysm patients

J. Michel, J. Egido, J. López, 2014, Proteomics. Clinical applications.

Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI

J. Egido, I. García, Nuria Genicio, 2015, Scientific Reports.

TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice

J. Egido, C. Gómez-Guerrero, L. Blanco-Colio, 2017, Scientific Reports.

Low‐Density Lipoprotein Cholesterol and High‐Sensitivity C‐Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study

J. Després, A. Langer, G. Gensini, 2012, Journal of clinical pharmacology.

Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm.

J. Michel, J. Egido, C. Pastor-Vargas, 2012, Atherosclerosis.

Clinical and Population Studies Identification of Peroxiredoxin-1 as a Novel Biomarker of Abdominal Aortic Aneurysm

J. Michel, E. Calvo, J. Egido, 2011 .

Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function

J. Carrero, L. Blanco-Colio, M. Yılmaz, 2013, European journal of clinical investigation.

www.elsevier.com/locate/cardiores Review Biology of atherosclerotic plaques:

J. Michel, J. Egido, F. Vivanco, 2006 .

Proteomic strategies in the search of new biomarkers in atherothrombosis.

J. Egido, J. López, L. Blanco-Colio, 2010, Journal of the American College of Cardiology.

HMGB1 Expression and Secretion Are Increased Via TWEAK–Fn14 Interaction in Atherosclerotic Plaques and Cultured Monocytes

L. Burkly, J. Egido, L. Blanco-Colio, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Soluble Fas ligand plasma levels are associated with forearm reactive hyperemia in subjects with coronary artery disease: a novel biomarker of endothelial function?

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2008, Atherosclerosis.

Protective effect of suppressor of cytokine signalling 1-based therapy in experimental abdominal aortic aneurysm.

I. Prieto, J. Egido, C. Gómez-Guerrero, 2020, British journal of pharmacology.

Pathophisiology of abdominal aortic aneurysm: biomarkers and novel therapeutic targets.

L. Blanco-Colio, J. Martín-Ventura, J. L. Martín-Ventura, 2019, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio

J. Michel, J. Egido, J. Emmerich, 2010, Arteriosclerosis, thrombosis, and vascular biology.

[Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice].

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2015, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

Phase IV prospective clinical study to evaluate the effect of taurine on liver function in postsurgical adult patients requiring parenteral nutrition.

J. Egido, J. I. Botella, L. Blanco-Colio, 2014, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

Annexins: Involvement in cholesterol homeostasis, inflammatory response and atherosclerosis.

L. Blanco-Colio, J. Martín-Ventura, N. Mendez-Barbero, 2021, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

Tweak/Fn14 system is involved in rhabdomyolysis-induced acute kidney injury.

C. Herencia, L. Blanco-Colio, Alfonso Rubio-Navarro, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2004, Stroke.

HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis.

J. Egido, Ó. López-Franco, C. Gómez-Guerrero, 2012, Cardiovascular research.

Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysms.

J. Egido, J. Lindholt, L. Blanco-Colio, 2011, Atherosclerosis.

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.

E. Fernández, J. Egido, L. Blanco-Colio, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Lipocalin-2, a potential therapeutic target in advanced atherosclerosis.

C. Pastor-Vargas, L. Blanco-Colio, J. Martín-Ventura, 2018, Atherosclerosis.

Soluble Fas ligand plasma levels are associated with forearm reactive hyperemia in subjects with coronary artery disease: a novel biomarker of endothelial function?

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2008, Atherosclerosis.

Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.

J. Egido, Ó. López-Franco, L. Blanco-Colio, 2010, Cardiovascular research.

In vitro 3D co-culture model of human endothelial and smooth muscle cells to study pathological vascular remodeling.

L. Blanco-Colio, Rafael Blázquez-Serra, Irene San Sebastian-Jaraba, 2024, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.